Call for paper：The 11th Cytokines and Inflammation Conference - 征文征稿 - 活动公告

Call for paper：The 11th Cytokines and Inflammation Conference

2012/11/13 9:33:20 ｜浏览：2997 ｜评论：0

Dear Colleague,

Register today to take advantage of the Early Registration Discount!
Save up to $350 to attend GTC's Cytokines and Inflammation conference, which has become an established meeting point for academic scientists and industry clinical developers to exchange their approaches in the field of cytokine biology.

Poster sessions and opportunities for networking will complement the great roster of distinguished speakers from big pharma and academic organizations. Participating companies include, Amgen, Bristol-Myers Squibb, Genentech, MedImmune, Biogen Idec, Merck Serono, Novo Nordisk. Join the discussion and network with top researchers from the City of Hope, FDA, NCI, NIH, USC, Sanford-Burnham, the Cleveland Clinic, UCLA, the University of Florida and more!

Session topics to be discussed at the conference are:
  • Therapeutic Applications of Cytokines and Chemokines
  • Cytokine Regulation
  • Cytokines in Health and Disease
  • Mucosal Homeostasis and Inflammation
  • Novel Technological Developments in Cytokines

Click Here to View the Agenda!

The 11th Cytokines & Inflammation conference is part of the 2nd Novel Immunotherapeutics Summit, which consists of this and three other tracks:
  • Immunogenicity & Immunotoxicity
  • 5th Immunotherapeutics & Immunomonitoring
  • 2nd Allergy Research & Drug Discovery

Attend the pre-conference Workshop：Immune Responses in Tumor Microenvironment
（Additional fee required）

Sign up today and save up to $350 before Nov 30, 2012!
Or Register for the whole Novel Immunotherapeutics Summit to get access to all four tracks.
Bring your team! Register two people at the regular price, bring a third person for free! Use discount code rcdvb.

DISTINGUISHED SPEAKERS

Ian Ahnfelt-Ronne, Corporate Vice President , Novo Nordisk A/S - FEATURED

Juan Carlos Lopez-Talavera, Vice President, Global Development Lead, Global Development & Medical Affairs, Research and Development, Bristol-Myers Squibb Company - FEATURED

Tomas Mustelin, Vice President, Research, Respiratory, Inflammatory, and Autoimmune Diseases, MedImmune - FEATURED

Joost J. Oppenheim, Chief, Laboratory of Molecular Immunoregulation, NIH, NCI - FEATURED

Ian Ahnfelt-Ronne, Corporate Vice President, Novo Nordisk A/S - FEATURED

Steven J. Bensinger, Assistant Professor, Institute for Molecular Medicine, UCLA

Raymond Donnelly, Senior Investigator, CBER Research, Office of Therapeutics Research and Review, Food and Drug Administration

Scott K. Durum, Chief, Section of Cytokines and Immunity, NIH, NCI

Grant Gallagher, Managing Director, and Head of Genetic Immunology, HUMIGEN, the Institute for Genetic Immunology

Ru Gunawardane, Sr. Scientist, Amgen

Arthur A. Hurwitz, Principal Investigator, Tumor Immunity and Tolerance Section, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Frederick National Laboratory for Cancer Research, CCR, NCI, NIH

Xiaoxia Li, Professor, Immunology, Lerner Research Institute（NB30）, The Cleveland Clinic Foundation

Nicholas W. Lukacs, Professor of Pathology, Assistant Dean for Faculty Affairs, University of Michigan Medical School

Christopher T. Migliaccio, Research Assistant Professor of Immunology, University of Montana

Martin Oft, Chief Executive Officer, Targenics

Amanda Proudfoot, Principal Scientist, Immunology, Merck Serono Geneva Research Centre

Carl D. Richards, Professor, Pathology and Molecular Medicine, McMaster Unversity

Robert C. Rickert, Professor and Director, Program on Inflammatory Diseases, Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute

Shahram Salek-Ardakani, Associate Professor, Pathology, Immunology and Laboratory of Medicine, University of Florida

William Stohl, Professor of Medicine, Chief, Division of Rheumatology, Keck School of Medicine of USC

Jennifer Towne, Principal Scientist, Amgen

Domagoj Vucic, Senior Scientist, Early Discovery Biochemistry, Genentech

Ji Ming Wang, Senior Investigator, Laboratory of Molecular Immunoregulation, Cancer and Inflammation Program, Center for Cancer, Research, Frederick National Laboratory for Cancer, Research, National Cancer Institute

Jon Wigginton, Executive Medical Director, Bristol-Myers Squibb

Howard A. Young, Principal Investigator & Deputy Lab Chief, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, Frederick National Laboratory for Cancer Research, CCR, NCI, NIH

Hua Yu, Associate Chair and Professor, Cancer Immunotherapeutics & Tumor Immunology, Beckman Research Institute at City of Hope Comprehensive Cancer Center

Timothy S. Zheng, Principal Scientist, R&D - Immunology, Biogen Idec

...and more!

For an updated speaker list, click here.
Register today and save 20% before Nov 30th!
Sign up 3 people for the price of 2! Use discount code rcdvb.

CALL FOR PAPERS!

To be considered for an oral presentation, please submit an abstract by December 30, 2012. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.

For Business Development & Exhibiting Opportunities contact Maribel Cortes at spex@gtcbio.com

Go to GTCbio.com to View Upcoming Conferences

相关栏目：『征文征稿』

Invitation：ISQPE Questionnaire Survey 2024 to 2025	2024-01-20	[1480]
2024年国际华人体育与健康学会年会研究摘要征集通知	2023-10-05	[5061]
2023年全球华人慈善研究国际研讨会（12/15-16）	2023-09-23	[5196]
复旦-UCSD当代中国研究中心：“中国焦点”征文比赛正式开启	2023-02-24	[997]
2023年加州教师协会：Call for Presenters	2023-02-10	[540]
第30屆環太平洋管理國際研討會徵文和邀請通知	2023-01-05	[2350]
2023年国际华人体育与健康学会年会（网上视频平台）	2022-11-04	[1788]
科普中国智库2022年会征文通知	2022-08-20	[1098]
中国长三角（江苏）— 新加坡产业创新合作计划首轮合作项目联合征集	2022-05-16	[981]
Call for Proposals for JMM 2023 Panels, Workshops, Events & Professional Enhancement Programs	2022-04-29	[1062]